Yasuhito Uezono Selected Research

Cisplatin (Platino)

7/2020	Peripherally administered cisplatin activates a parvocellular neuronal subtype expressing arginine vasopressin and enhanced green fluorescent protein in the paraventricular nucleus of a transgenic rat.
7/2018	Possible involvement of central oxytocin in cisplatin-induced anorexia in rats.
9/2017	Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).
9/2015	Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.
8/2013	The gene expression of the hypothalamic feeding-regulating peptides in cisplatin-induced anorexic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhito Uezono Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 08/2012
21	Pain (Aches) 01/2024 - 05/2004
13	Neuralgia (Stump Neuralgia) 07/2022 - 07/2013
12	Cachexia 10/2023 - 08/2012
11	Anorexia 10/2023 - 11/2012
7	Stomatitis 12/2022 - 09/2013
7	Hyperalgesia 01/2021 - 11/2008
6	Cancer Pain 01/2022 - 01/2014
5	Weight Loss (Weight Reduction) 10/2023 - 11/2012
5	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2013
5	Intractable Pain 04/2020 - 03/2014
4	Mucositis 01/2021 - 05/2016
3	Vomiting 01/2024 - 09/2017
3	Chronic Pain 01/2021 - 11/2008
3	Constipation 01/2020 - 11/2012
3	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2018
3	Peripheral Nervous System Diseases (PNS Diseases) 07/2019 - 01/2014
2	Nausea 01/2024 - 09/2017
2	Delirium 08/2023 - 11/2022
2	Emergence Delirium 08/2023 - 11/2022
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2021
2	Cardiotoxicity 01/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
2	Anxiety Disorders (Anxiety Disorder) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 09/2014
2	Heart Failure 01/2020 - 02/2005
2	Atrophy 12/2018 - 11/2015
2	Fatigue 01/2018 - 11/2012
2	Dyspepsia (Indigestion) 09/2017 - 01/2015
2	Body Weight (Weight, Body) 01/2017 - 01/2014
2	Diarrhea 01/2017 - 09/2013
2	Ulcer 05/2016 - 01/2015
2	Hypesthesia (Numbness) 11/2015 - 11/2012
2	Ileus 04/2015 - 01/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2015 - 01/2015
2	Gastroesophageal Reflux (GERD) 01/2015 - 11/2009
2	Bone Neoplasms (Bone Cancer) 10/2014 - 01/2014
1	Chronic Disease (Chronic Diseases) 10/2023
1	Frailty 10/2023

Drug/Important Bio-Agent (IBA)

10	Analgesics (Analgesic Drugs)IBA 09/2021 - 01/2014
9	liu-jun-zi-tangIBA 12/2018 - 08/2013
8	Opioid Analgesics (Opioids)IBA 07/2022 - 07/2013
8	Opioid Receptors (Opioid Receptor)IBA 07/2022 - 10/2012
6	Morphine (MS Contin)FDA LinkGeneric 07/2022 - 11/2008
6	Voltage-Gated Sodium ChannelsIBA 01/2021 - 03/2014
5	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 08/2013
4	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 11/2008
3	Methadone (Dolophine)FDA LinkGeneric 01/2022 - 01/2018
3	EnzymesIBA 01/2020 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2014
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 03/2002
3	GhrelinIBA 01/2017 - 01/2014
3	gosha-jinki-ganIBA 11/2015 - 09/2013
3	Tramadol (K315)FDA LinkGeneric 10/2015 - 03/2002
3	NeuropeptidesIBA 09/2015 - 01/2007
3	Substance PIBA 04/2014 - 12/2010
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2024 - 11/2008
2	Yi-Gan SanIBA 11/2022 - 09/2013
2	Therapeutic UsesIBA 09/2021 - 01/2020
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2021 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2017
2	Dinoprostone (PGE2)FDA Link 01/2020 - 09/2014
2	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 07/2019 - 05/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 12/2018
2	Pregnanolone (Allopregnanolone)IBA 05/2018 - 09/2014
2	Peptides (Polypeptides)IBA 01/2018 - 08/2013
2	AntiemeticsIBA 09/2017 - 04/2014
2	Platelet Activating FactorIBA 01/2017 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 05/2016
2	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 01/2017 - 01/2014
2	Acetic Acid (Vinegar)FDA LinkGeneric 05/2016 - 01/2015
2	Capsaicin (Zostrix)FDA Link 02/2016 - 01/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015 - 01/2014
2	Lidocaine (Xylocaine)FDA LinkGeneric 03/2015 - 01/2015
2	Small Interfering RNA (siRNA)IBA 10/2014 - 01/2014
2	CatecholaminesIBA 02/2005 - 03/2002
1	Cytochrome P-450 CYP3AIBA 01/2024
1	Cytochrome P-450 CYP2D6 InhibitorsIBA 01/2024
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2024
1	C-Reactive ProteinIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	ramelteon (Rozerem)FDA Link 08/2023
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022
1	G Protein-Coupled Inwardly-Rectifying Potassium ChannelsIBA 07/2022
1	Interferon Type IIBA 02/2022
1	InterferonsIBA 02/2022
1	AlkaloidsIBA 02/2022

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2022 - 03/2014
11	Therapeutics 10/2023 - 12/2007
6	Ligation 07/2022 - 01/2017
6	Oral Administration 12/2020 - 02/2014
5	Kampo Medicine (Kampo) 01/2018 - 11/2012
4	Radiotherapy 01/2024 - 01/2016
3	Palliative Care (Palliative Therapy) 12/2022 - 11/2012
2	Analgesia 09/2021 - 03/2002
2	Spinal Injections 10/2014 - 01/2014
2	Transplantation 10/2014 - 01/2014
1	Polypharmacy 01/2024
1	Drug Tapering 01/2024
1	Gastrectomy 08/2023